相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic
Ashok Aspatwar et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2022)
BCG vaccination in health care providers and the protection against COVID-19
Mihai G. Netea et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Hidden in plain sight: The effects of BCG vaccination in the COVID-19 pandemic
Eman A. Toraih et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
COULD NEW COVID VARIANTS UNDERMINE VACCINES? LABS SCRAMBLE TO FIND OUT
Ewen Callaway
NATURE (2021)
Complexity analysis of cold chain transportation in a vaccine supply chain considering activity inspection and time-delay
Daoming Dai et al.
ADVANCES IN DIFFERENCE EQUATIONS (2021)
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
Summer E. Galloway et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020
Sara E. Oliver et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries
Malia Skjefte et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
Kathryn E. Stephenson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Building public trust in COVID-19 vaccines through the Catholic Church in the Philippines
Jose Ma W. Gopez
JOURNAL OF PUBLIC HEALTH (2021)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey et al.
LANCET (2021)
Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics
J. Peter Figueroa et al.
LANCET (2021)
Sputnik V COVID-19 vaccine candidate appears safe and effective Comment
Ian Jones et al.
LANCET (2021)
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang et al.
NATURE (2021)
The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region
Justin R. Ortiz et al.
VACCINE (2021)
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
Darrell O. Ricke
FRONTIERS IN IMMUNOLOGY (2021)
Pervasive transmission of E484K and emergence of VUI-NP13L with evidence of SARS-CoV-2 co-infection events by two different lineages in Rio Grande do Sul, Brazil
Ronaldo da Silva Francisco Jr et al.
VIRUS RESEARCH (2021)
Peptides-Based Vaccine MP3RT Induced Protective Immunity Against Mycobacterium Tuberculosis Infection in a Humanized Mouse Model
Wenping Gong et al.
FRONTIERS IN IMMUNOLOGY (2021)
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil
Carolina Kymie Vasques Nonaka et al.
EMERGING INFECTIOUS DISEASES (2021)
Geospatial Analysis of Age-specific SARS-CoV-2 Transmission Patterns in Households, Korea
Seonju Yi et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Review of COVID-19 Vaccines and Their Evidence in Older Adults
Shyh Poh Teo
ANNALS OF GERIATRIC MEDICINE AND RESEARCH (2021)
Knowledge and practice of vaccination logistics management among primary health care workers in Nigeria
Wasiu Olalekan Adebimpe et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Prevention of tuberculosis in macaques after intravenous BCG immunization
Patricia A. Darrah et al.
NATURE (2020)
Design and Optimization of a Temperature-Stable Dry Powder BCG Vaccine
Dominique N. Price et al.
PHARMACEUTICAL RESEARCH (2020)
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Mayda Gursel et al.
ALLERGY (2020)
Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
Mihai G. Netea et al.
CELL (2020)
SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
Uri Hamiel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Safety and Optimal Timing of BCG Vaccination in Infants Born to Mothers Receiving Anti-TNF Therapy for Inflammatory Bowel Disease
Sang Hyoung Park et al.
JOURNAL OF CROHNS & COLITIS (2020)
Treatment options for COVID-19: The reality and challenges
Shio-Shin Jean et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
Camila Covian et al.
FRONTIERS IN IMMUNOLOGY (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology
Robert L. Garcea et al.
NPJ VACCINES (2020)
BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment
Branko Cirovic et al.
CELL HOST & MICROBE (2020)
COVID-19: Could India still escape?
Ashwin Rammohan et al.
JOURNAL OF GLOBAL HEALTH (2020)
Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19
JingKang Sun et al.
POSTGRADUATE MEDICINE (2020)
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
Luis E. Escobar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?
Wenping Gong et al.
Indian Journal of Tuberculosis (2020)
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
Liangwei Duan et al.
FRONTIERS IN IMMUNOLOGY (2020)
On the relationship between BCG coverage and national COVID-19 outcome: could 'heterologous' herd immunity explain why some countries are better off?
M. Lerm
JOURNAL OF INTERNAL MEDICINE (2020)
An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19
Lucy Chimoyi et al.
PLOS ONE (2020)
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
Jeffrey E. Gold et al.
MBIO (2020)
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Lizhou Zhang et al.
NATURE COMMUNICATIONS (2020)
A review of the safety of vaccines used in routine immunization in Africa
Peter Yamoah et al.
AFRICAN HEALTH SCIENCES (2020)
Defining trained immunity and its role in health and disease
Mihai G. Netea et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Trained immunity as a novel approach against COVID-19 with a focus on Bacillus Calmette-Guerin vaccine: mechanisms, challenges and perspectives
Yahya Sohrabi et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Emerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation
Joachim L. Schultze et al.
IMMUNITY (2019)
Outcomes of controlled human malaria infection after BCG vaccination
Jona Walk et al.
NATURE COMMUNICATIONS (2019)
RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice
Satria A. Prabowo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Antibodies and vaccines against Middle East respiratory syndrome coronavirus
Jiuyang Xu et al.
EMERGING MICROBES & INFECTIONS (2019)
Immune Training Unlocks Innate Potential
Wilbur M. Song et al.
CELL (2018)
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity
Ioannis Mitroulis et al.
CELL (2018)
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
Eva Kaufmann et al.
CELL (2018)
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
Rob J. W. Arts et al.
CELL HOST & MICROBE (2018)
The current status, challenges, and future developments of new tuberculosis vaccines
Wenping Gong et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial beta-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies
Ashok Aspatwar et al.
MOLECULES (2018)
Viral-Induced Enhanced Disease Illness
Maria K. Smatti et al.
FRONTIERS IN MICROBIOLOGY (2018)
Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
Andre G. Loxton et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
The Recombinant Bacille Calmette-Guerin Vaccine VPM1002: Ready for Clinical Efficacy Testing
Natalie E. Nieuwenhuizen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Sleeping Beauty and the Story of the Bacille Calmette-Guerin Vaccine
Helen A. Fletcher
MBIO (2016)
Immunometabolic Pathways in BCG-Induced Trained Immunity
Rob J. W. Arts et al.
CELL REPORTS (2016)
Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination
A. C. Hesseling et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized, Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection
Andre S. Nell et al.
PLOS ONE (2014)
mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity
Shih-Chin Cheng et al.
SCIENCE (2014)
Latent Enhancers Activated by Stimulation in Differentiated Cells
Renato Ostuni et al.
CELL (2013)
Treatment of Common and Plane Warts in Children with Topical Viable Bacillus Calmette-Guerin
Ahmed Salem et al.
PEDIATRIC DERMATOLOGY (2013)
Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial
Leander Grode et al.
VACCINE (2013)
Nonclinical Development of BCG Replacement Vaccine Candidates
Kamalakannan Velmurugan et al.
VACCINES (2013)
Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
Johanneke Kleinnijenhuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Trained Immunity: A Memory for Innate Host Defense
Mihai G. Netea et al.
CELL HOST & MICROBE (2011)
New therapeutic approach for latent tuberculosis infection
Sandeep Kumar Gupta
LUNG INDIA (2011)
Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®
C. Vilaplana et al.
VACCINE (2010)
Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS
Brigitte Autran et al.
EXPERT REVIEW OF VACCINES (2009)
Coronaviruses post-SARS: update on replication and pathogenesis
Stanley Perlman et al.
NATURE REVIEWS MICROBIOLOGY (2009)
RUTI: A new chance to shorten the treatment of latent tuberculosis infection
Pere-Joan Cardona
TUBERCULOSIS (2006)